Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Mynarek

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Cancers|December 10, 2021
SIOP PNET5 MB Trial: History and Concept of a Molecularly Stratified Clinical Trial of Risk-Adapted Therapies for Standard-Risk MedulloblastomaMartin Mynarek, Till Milde, Laetitia Padovani, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|June 1, 2020
Ependymomas in infancy: underlying genetic alterations, histological features, and clinical outcomeStephanie T Jünger, Felipe Andreiuolo, Martin Mynarek, et al.
Journal of Neuro-Oncology|September 16, 2025
One-year follow-up of the new European reference network for pediatric cancers (ERN PaedCan) tumor board for pediatric CNS tumors: lessons learnt and future prospectsMarthe Sönksen, Brigitte Bison, Lisa Bußenius, et al.
Pediatric Blood & Cancer|May 18, 2021
Follow-up evaluation of a web-based pediatric brain tumor board in Latin AmericaMariel Rosabal-Obando, Diana S Osorio, Alvaro Lassaletta, et al.
Klinische Padiatrie|May 12, 2023
[Pediatric Intracranial Ependymoma - Recommendations for First-Line Treatment from the German HIT-MED study group]Denise Obrecht, Martin Mynarek, Martina Stickan-Verfürth, et al.
Acta Neuropathologica Communications|November 26, 2025
Recurrent genetic alterations in epigenetically defined pineoblastoma subtypesTobias Goschzik, Mathias Yuan, Elke Pfaff, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2015
Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacyRaisa S Pompe, André O von Bueren, Martin Mynarek, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 26, 2013
Patient, virus, and treatment-related risk factors in pediatric adenovirus infection after stem cell transplantation: results of a routine monitoring programMartin Mynarek, Tina Ganzenmueller, Annika Mueller-Heine, et al.
Radiation Oncology (London, England)|January 28, 2023
G2 checkpoint targeting via Wee1 inhibition radiosensitizes EGFRvIII-positive glioblastoma cellsMeryem H Cetin, Thorsten Rieckmann, Konstantin Hoffer, et al.
Acta Neuropathologica|October 1, 2022
Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomasTobias Goschzik, Martin Mynarek, Evelyn Doerner, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Cancers|December 10, 2021
SIOP PNET5 MB Trial: History and Concept of a Molecularly Stratified Clinical Trial of Risk-Adapted Therapies for Standard-Risk MedulloblastomaMartin Mynarek, Till Milde, Laetitia Padovani, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|June 1, 2020
Ependymomas in infancy: underlying genetic alterations, histological features, and clinical outcomeStephanie T Jünger, Felipe Andreiuolo, Martin Mynarek, et al.
Journal of Neuro-Oncology|September 16, 2025
One-year follow-up of the new European reference network for pediatric cancers (ERN PaedCan) tumor board for pediatric CNS tumors: lessons learnt and future prospectsMarthe Sönksen, Brigitte Bison, Lisa Bußenius, et al.
Pediatric Blood & Cancer|May 18, 2021
Follow-up evaluation of a web-based pediatric brain tumor board in Latin AmericaMariel Rosabal-Obando, Diana S Osorio, Alvaro Lassaletta, et al.
Klinische Padiatrie|May 12, 2023
[Pediatric Intracranial Ependymoma - Recommendations for First-Line Treatment from the German HIT-MED study group]Denise Obrecht, Martin Mynarek, Martina Stickan-Verfürth, et al.
Acta Neuropathologica Communications|November 26, 2025
Recurrent genetic alterations in epigenetically defined pineoblastoma subtypesTobias Goschzik, Mathias Yuan, Elke Pfaff, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2015
Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacyRaisa S Pompe, André O von Bueren, Martin Mynarek, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 26, 2013
Patient, virus, and treatment-related risk factors in pediatric adenovirus infection after stem cell transplantation: results of a routine monitoring programMartin Mynarek, Tina Ganzenmueller, Annika Mueller-Heine, et al.
Radiation Oncology (London, England)|January 28, 2023
G2 checkpoint targeting via Wee1 inhibition radiosensitizes EGFRvIII-positive glioblastoma cellsMeryem H Cetin, Thorsten Rieckmann, Konstantin Hoffer, et al.
Acta Neuropathologica|October 1, 2022
Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomasTobias Goschzik, Martin Mynarek, Evelyn Doerner, et al.
Pageof 10